Yttrium Y 90 Ibritumomab Tiuxetan and Rituximab in Treating Patients With Non-Hodgkin's Lymphoma
Completed · Phase 2
Conditions studied: Lymphoma
In brief
RATIONALE: Monoclonal antibodies such as yttrium Y 90 ibritumomab tiuxetan and rituximab can locate cancer cells and either kill them or deliver radioactive cancer-killing substances to them without harming normal cells. PURPOSE: This phase II trial is studying how well giving yttrium Y 90 ibritumomab tiuxetan together with rituximab works in treating patients with progressive non-Hodgkin's lymphoma.
Key facts
- Study ID
- NCT00062114
- Run by
- Alliance for Clinical Trials in Oncology
- People needed
- 84
- Starts
- 2004-04-01
- Expected to finish
- 2007-04-01
- Last updated by the study team
- 2016-07-06
Who can join
Age: 18 and older. Sex: any. Healthy volunteers: not accepted.
Where it is running
- Providence Saint Joseph Medical Center - Burbank — Burbank, California, United States
- Moores UCSD Cancer Center — La Jolla, California, United States
- Kaiser Permanente Medical Office -Vandever Medical Office — San Diego, California, United States
- Beebe Medical Center — Lewes, Delaware, United States
- CCOP - Christiana Care Health Services — Newark, Delaware, United States
- Rush-Copley Cancer Care Center — Aurora, Illinois, United States
- University of Illinois Cancer Center — Chicago, Illinois, United States
- University of Chicago Cancer Research Center — Chicago, Illinois, United States
- Joliet Oncology-Hematology Associates, Limited - West — Joliet, Illinois, United States
- Carle Cancer Center at Carle Foundation Hospital — Urbana, Illinois, United States
- CCOP - Carle Cancer Center — Urbana, Illinois, United States
- St. Francis Hospital and Health Centers - Beech Grove Campus — Beech Grove, Indiana, United States
- Saint Anthony Memorial Health Centers — Michigan City, Indiana, United States
- Reid Hospital & Health Care Services, Incorporated — Richmond, Indiana, United States
- Tammy Walker Cancer Center at Salina Regional Health Center — Salina, Kansas, United States
- Cotton-O'Neil Cancer Center — Topeka, Kansas, United States
- St. Francis Comprehensive Cancer Center — Topeka, Kansas, United States
- Central Maine Comprehensive Cancer Center at Central Maine Medical Center — Lewiston, Maine, United States
- Union Hospital Cancer Program at Union Hospital — Elkton MD, Maryland, United States
- Dana-Farber/Brigham and Women's Cancer Center — Boston, Massachusetts, United States
- Dana-Farber/Harvard Cancer Center at Dana Farber Cancer Institute — Boston, Massachusetts, United States
- Cancer Research Center at Boston Medical Center — Boston, Massachusetts, United States
- West Michigan Cancer Center — Kalamazoo, Michigan, United States
- Bronson Methodist Hospital — Kalamazoo, Michigan, United States
- Arkansas Cancer Research Center at University of Arkansas for Medical Sciences — Little Rock, Arkansas, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.